Type 2 Diabetes-Induced Molecular and Functional Impairment of Adipose Tissue-Derived Mesenchymal Stromal Cells (ASCs) and Interferon Gamma Priming for Enhanced Diabetic ASC-Based Therapy.

IF 4.9 3区 医学 Q2 CELL & TISSUE ENGINEERING
Stem Cell Reviews and Reports Pub Date : 2026-08-01 Epub Date: 2026-06-04 DOI:10.1007/s12015-026-11164-y
Alaa Zeinhom, Ammar Y Mohamed, Nahla N Abdel-Aziz, Mostafa Sayed Diab, Amir M H Salem, Noha N Yassen, Eman E A Mohammed, Amal M Mohamed, Ola M Eid, Shymaa H Hussein, Marwa Farid, Engy K Tharwat, Kholoud A Ali, Hesham A Elmeligy, Sahar A Fadallah, Osama Azmy, Nourhan Abu-Shahba, Marwa Mahmoud
{"title":"Type 2 Diabetes-Induced Molecular and Functional Impairment of Adipose Tissue-Derived Mesenchymal Stromal Cells (ASCs) and Interferon Gamma Priming for Enhanced Diabetic ASC-Based Therapy.","authors":"Alaa Zeinhom, Ammar Y Mohamed, Nahla N Abdel-Aziz, Mostafa Sayed Diab, Amir M H Salem, Noha N Yassen, Eman E A Mohammed, Amal M Mohamed, Ola M Eid, Shymaa H Hussein, Marwa Farid, Engy K Tharwat, Kholoud A Ali, Hesham A Elmeligy, Sahar A Fadallah, Osama Azmy, Nourhan Abu-Shahba, Marwa Mahmoud","doi":"10.1007/s12015-026-11164-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Transplantation of adipose-derived mesenchymal stromal cells (ASCs) or their insulin-producing derivatives holds promise for diabetes mellitus therapy due to their regenerative properties. However, the harsh microenvironment in type 2 diabetes (T2D) likely impairs autologous ASC efficacy.</p><p><strong>Aim: </strong>This study investigated transcriptomic alterations and therapeutic efficacy of ASCs from T2D patients (dASCs) in experimental diabetes, compared to healthy donors (ndASCs), and evaluated whether inflammatory priming could enhance dASC functionality.</p><p><strong>Methods: </strong>dASCs and ndASCs were characterized phenotypically and functionally. Differentially expressed genes (DEGs) were identified via microarray profiling of basal and IFN-γ/TNF-α-primed cells. miRNA-transcription factor (TF) coregulatory networks were constructed for key DEGs. In vivo, anti-hyperglycemic effects, islet regeneration, insulin expression, and local inflammation modulation were assessed in streptozotocin (STZ)-induced diabetic rats by transplanting dASCs, ndASCs, or IFN-γ-primed dASCs (p.dASCs).</p><p><strong>Results: </strong>DEGs in dASCs were significantly enriched in inflammation, glycerolipid metabolism, cell adhesion, cytoskeleton remodeling, angiogenesis, and insulin or hypoxia-related responses. EGFR/ERBB2 signaling, with downstream Ras/MAPK and PI3K/AKT cascades, and endocrine resistance-related pathways were significantly overrepresented. Although inflammatory responses were broadly shared, cytokine priming further exacerbated endocrine resistance and oxidative phosphorylation defects-associated transcriptomic signatures in dASCs. Key DEGs (EGFR, ERBB2, ESR1, FOS, IL1B, JUN, KRAS, MMP9, RUNX2) were identified as contributors to insulin resistance-related pathways and were used to construct a miRNA-TF coregulatory circuit for mechanistic and therapeutic hypothesis-generation. In the STZ-diabetes model, dASCs displayed limited regenerative capacity and attenuated immunomodulatory function; however, these potentials were partially restored by p.dASCs. Favorable trends in glycemic control parameters were observed with ndASCs, and C-peptide levels were significantly higher in p.dASC-treated rats compared with those receiving non-primed dASCs.</p><p><strong>Conclusion: </strong>The study suggests a multifaceted dysregulated transcriptomic signature in dASCs, prominently including endocrine resistance-related pathways. The therapeutic efficacy of dASCs is partially rescued by IFN-γ priming, which supports the potential of tailored preconditioning strategies for improving autologous cell therapy in diabetes.</p>","PeriodicalId":21955,"journal":{"name":"Stem Cell Reviews and Reports","volume":" ","pages":"2879-2901"},"PeriodicalIF":4.9000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cell Reviews and Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12015-026-11164-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Transplantation of adipose-derived mesenchymal stromal cells (ASCs) or their insulin-producing derivatives holds promise for diabetes mellitus therapy due to their regenerative properties. However, the harsh microenvironment in type 2 diabetes (T2D) likely impairs autologous ASC efficacy.

Aim: This study investigated transcriptomic alterations and therapeutic efficacy of ASCs from T2D patients (dASCs) in experimental diabetes, compared to healthy donors (ndASCs), and evaluated whether inflammatory priming could enhance dASC functionality.

Methods: dASCs and ndASCs were characterized phenotypically and functionally. Differentially expressed genes (DEGs) were identified via microarray profiling of basal and IFN-γ/TNF-α-primed cells. miRNA-transcription factor (TF) coregulatory networks were constructed for key DEGs. In vivo, anti-hyperglycemic effects, islet regeneration, insulin expression, and local inflammation modulation were assessed in streptozotocin (STZ)-induced diabetic rats by transplanting dASCs, ndASCs, or IFN-γ-primed dASCs (p.dASCs).

Results: DEGs in dASCs were significantly enriched in inflammation, glycerolipid metabolism, cell adhesion, cytoskeleton remodeling, angiogenesis, and insulin or hypoxia-related responses. EGFR/ERBB2 signaling, with downstream Ras/MAPK and PI3K/AKT cascades, and endocrine resistance-related pathways were significantly overrepresented. Although inflammatory responses were broadly shared, cytokine priming further exacerbated endocrine resistance and oxidative phosphorylation defects-associated transcriptomic signatures in dASCs. Key DEGs (EGFR, ERBB2, ESR1, FOS, IL1B, JUN, KRAS, MMP9, RUNX2) were identified as contributors to insulin resistance-related pathways and were used to construct a miRNA-TF coregulatory circuit for mechanistic and therapeutic hypothesis-generation. In the STZ-diabetes model, dASCs displayed limited regenerative capacity and attenuated immunomodulatory function; however, these potentials were partially restored by p.dASCs. Favorable trends in glycemic control parameters were observed with ndASCs, and C-peptide levels were significantly higher in p.dASC-treated rats compared with those receiving non-primed dASCs.

Conclusion: The study suggests a multifaceted dysregulated transcriptomic signature in dASCs, prominently including endocrine resistance-related pathways. The therapeutic efficacy of dASCs is partially rescued by IFN-γ priming, which supports the potential of tailored preconditioning strategies for improving autologous cell therapy in diabetes.

2型糖尿病诱导的脂肪组织源性间充质细胞(ASCs)的分子和功能损伤和干扰素γ启动增强糖尿病asc基础治疗
背景:脂肪来源的间充质基质细胞(ASCs)或其产生胰岛素的衍生物的移植由于其再生特性为糖尿病的治疗带来了希望。然而,2型糖尿病(T2D)患者恶劣的微环境可能会损害自体ASC的疗效。目的:本研究探讨实验性糖尿病T2D患者(dASCs)与健康供体(ndASCs)的ASCs的转录组学改变和治疗效果,并评估炎症启动是否可以增强dASC的功能。方法:对dASCs和ndASCs进行表型和功能表征。差异表达基因(DEGs)通过微阵列分析鉴定基底细胞和IFN-γ/TNF-α-引物细胞。构建了mirna -转录因子(TF)调控网络。在体内,通过移植dASCs、ndASCs或IFN-γ-引物dASCs (p.dASCs)来评估链脲佐菌(STZ)诱导的糖尿病大鼠的抗高血糖作用、胰岛再生、胰岛素表达和局部炎症调节。结果:dscs中的DEGs在炎症、甘油脂代谢、细胞粘附、细胞骨架重塑、血管生成以及胰岛素或缺氧相关反应中显著富集。EGFR/ERBB2信号,下游Ras/MAPK和PI3K/AKT级联,以及内分泌抵抗相关途径被显著高估。尽管炎症反应是广泛共享的,但细胞因子启动进一步加剧了dASCs中内分泌抵抗和氧化磷酸化缺陷相关的转录组特征。关键deg (EGFR, ERBB2, ESR1, FOS, IL1B, JUN, KRAS, MMP9, RUNX2)被确定为胰岛素抵抗相关途径的参与者,并用于构建miRNA-TF协同调节回路,以产生机制和治疗假设。在stz -糖尿病模型中,dASCs表现出有限的再生能力和减弱的免疫调节功能;然而,这些电位被p.dASCs部分恢复。服用ndASCs后,血糖控制指标有良好的变化趋势。与未服用ndASCs的大鼠相比,服用p.d asc的大鼠c肽水平显著升高。结论:该研究表明dassc中存在多方面的转录组失调信号,其中包括内分泌抵抗相关途径。IFN-γ启动部分挽救了dASCs的治疗效果,这支持了定制预处理策略改善糖尿病自体细胞治疗的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Stem Cell Reviews and Reports
Stem Cell Reviews and Reports 医学-细胞生物学
CiteScore
9.30
自引率
4.20%
发文量
0
审稿时长
3 months
期刊介绍: The purpose of Stem Cell Reviews and Reports is to cover contemporary and emerging areas in stem cell research and regenerative medicine. The journal will consider for publication: i) solicited or unsolicited reviews of topical areas of stem cell biology that highlight, critique and synthesize recent important findings in the field. ii) full length and short reports presenting original experimental work. iii) translational stem cell studies describing results of clinical trials using stem cells as therapeutics. iv) papers focused on diseases of stem cells. v) hypothesis and commentary articles as opinion-based pieces in which authors can propose a new theory, interpretation of a controversial area in stem cell biology, or a stem cell biology question or paradigm. These articles contain more speculation than reviews, but they should be based on solid rationale. vi) protocols as peer-reviewed procedures that provide step-by-step descriptions, outlined in sufficient detail, so that both experts and novices can apply them to their own research. vii) letters to the editor and correspondence. In order to facilitate this exchange of scientific information and exciting novel ideas, the journal has created five thematic sections, focusing on: i) the role of adult stem cells in tissue regeneration; ii) progress in research on induced pluripotent stem cells, embryonic stem cells and mechanism governing embryogenesis and tissue development; iii) the role of microenvironment and extracellular microvesicles in directing the fate of stem cells; iv) mechanisms of stem cell trafficking, stem cell mobilization and homing with special emphasis on hematopoiesis; v) the role of stem cells in aging processes and cancerogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书